FierceBiotech
  • FierceBiotech
  • FierceBiotechIT
  • FierceBiotechResearch
  • FierceBiomarkers
  • FierceDrugDelivery
  • FierceMedicalDevices
  • FierceVaccines
  • FiercePharma
  • FiercePharmaManufacturing
  • FierceCRO
  • More Fierce Network sites
  • Select another site
  • Advertise
  • Contact

Free Daily Biotech Industry Newsletter Get the latest on Biotech & Pharma Deals, Clinical Trials, FDA Decisions, and Key Regulatory Issues sent straight to your Inbox. Join over 100,000 biotech professionals who subscribe to FierceBiotech for FREE! Click here to see a sample.

FierceBiotech

  • News
  • TOPICS
    • Biosimilars
    • Chutes and Ladders
    • Clinical Trials
    • Drug Safety
    • Emerging Markets
    • Europe
    • M&A
    • Outsourcing
    • Partnering
    • Personalized Medicine
    • Pipeline
    • R&D
    • Regulatory
  • ANALYSIS
    • Third Rock's Levin calls for teamwork in personalized medicine
      by Damian Garde
    • Readers' picks, responses to Fierce's 'Top 10' cancer drugs report
      by Ryan McBride
    • More commentary
  • FEATURES
    • The Biggest R&D Spenders in Biotech
    • The Biggest R&D Spenders In Biopharma
    • Top 10 Late-Stage Cancer Drugs – 2012
  • LIBRARY
    • Webinars
    • View All
  • EVENTS
  • JOBS
    • Browse Jobs
    • Post a Job
  • Marketplace
  • Susbscribe
  • Twitter
  • Mobile
Follow US
Tag:

GPCR

Latest Headlines

Latest Headlines

Hot Heptares inks $200M tech pact with Novartis

October 12, 2009
The UK's fledgling Heptares Therapeutics has scored a $200 million collaboration pact with Novartis, putting its technology to work to identify novel drug candidates that can hit a designated

Related Tags

  • Omeros
  • epigenetics
  • central nervous system
  • biopharmaceutical company

GPCR Press Releases

  • Receptos Scientists Publish Determination of a High Resolution Sphingosine 1-Phosphate Receptor 1 Structure in Science
  • Trevena Initiates Clinical Development of TRV130, a Biased Mu-Opioid Ligand for Severe Post-Operative Pain
  • Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs
  • Receptos and Ono Establish Collaboration with Focus on Bioactive Lipid Discovery Research
  • Omeros to Present at 23rd Annual Piper Jaffray Health Care Conference

Join 100,000+ Insiders SIGN UP FOR OUR NEWSLETTER

THE LIBRARY: WEBINAR

Getting the most PoC data in Phase I cancer studies

| June 12, 11am ET/ 8am PT

The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!

MORE ITEMS

EVENTS

  • MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
  • Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
  • What's your BIO?June 18-21, 2012 — Boston, MA
MORE EVENTS

Press Releases

  • Chronic Pain Is Relieved by Cell Transplantation in Lab Study
  • Drug-vaccine combo better for breast cancer
  • Marked for destruction: Newly developed compound triggers cancer cell death
  • Orthofix International Completes Divestiture of Sports Medicine Business Unit
  • ConforMIS iTotal CR Knee Replacement System Wins Silver in 2012 Medical Design Excellence Awards
  • More Press Releases

Featured Jobs

  • Analytical Scientist Job
    Yoh - Durham, NC, USA
  • Pharmacist (Drug Safety and Product Information) Job
    Yoh - Durham, NC, USA
  • Director, Safety Pharmacology and Toxicology
    Tesaro - Waltham, MA
  • Research & Development Chemist
    C3 Jian - Marina Del Rey, CA
  • Pilot Manufacturing Scientist Job
    Yoh - Cambridge, MA, USA

A publication of FierceMarkets

FierceBiotech monitors biotech & pharma deals, FDA decisions, clinical trials, and more. Join more than 100,000 biotech industry leaders who subscribe to our free daily email. Click here to get your free weekly email briefing today!

The FierceMarkets Network:

Telecom
  • FierceWireless
  • FierceBroadbandWireless
  • FierceMobileContent
  • FierceDeveloper
  • FierceWireless:Europe
  • FierceTelecom
  • FierceEnterpriseCommunications
  • FierceIPTV
  • FierceOnlineVideo
  • FierceCable
Healthcare
  • FierceHealthcare
  • FiercePracticeManagement
  • FierceHealthIT
  • FierceHealthFinance
  • Hospital Impact
  • FierceEMR
  • FierceMobileHealthcare
  • FierceHealthPayer
Government
  • FierceGovernment
  • FierceGovernmentIT
  • FierceHomelandSecurity
Energy
  • FierceEnergy
  • FierceSmartGrid
Life Sciences
  • FierceBiotech
  • FierceBiotechResearch
  • FiercePharma
  • FierceVaccines
  • FierceBiotechIT
  • FiercePharmaManufacturing
  • FierceMedicalDevices
  • FierceDrugDelivery
  • FierceBiomarkers
  • FierceCRO
Enterprise IT
  • FierceCIO
  • FierceCIO:TechWatch
  • FierceMobileIT
  • FierceContentManagement
Finance
  • FierceFinance
  • FierceComplianceIT
  • FierceFinanceIT
  • Home
  • Subscribe
  • Advertise
  • Mobile Edition
  • RSS
  • Privacy
  • Editors
© 2012 FierceMarkets. All rights reserved.